Aikium Inc. is a biotechnology company founded in 2022 and headquartered in Berkeley, California. The company develops AI-driven platforms for protein screening and engineering, including its Yotta-ML protein screening technology and a family of "Aiki" foundation models for predicting protein phenotypes such as expression and solubility. Aikium applies these tools to protein therapeutics in areas including neuro-inflammation and oncology.
Models (1)
———
Leakage-controlled multimodal model predicting within-species relative protein expression across 385 bacterial species, with transfer to unseen phyla.
Protein